Colorado PROFILES, The Colorado Clinical and Translational Sciences Institute (CCTSI)
Keywords
Last Name
Institution

Contact Us
If you have any questions or feedback please contact us.

Adane Wogu

Concepts (118)

Concepts are derived automatically from a person's publications.

Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.

Name Number of Publications Most Recent Publication Publications by All Authors Concept Score Why?
Antifibrinolytic Agents
2
2025
68
1.020
Why?
Tranexamic Acid
2
2025
63
1.010
Why?
Hemorrhage
3
2025
825
0.880
Why?
Wounds and Injuries
2
2025
959
0.590
Why?
Cohort Studies
7
2025
6077
0.560
Why?
Outpatients
4
2025
440
0.490
Why?
South Africa
4
2025
262
0.350
Why?
Birth Weight
1
2014
521
0.340
Why?
Gestational Age
1
2014
990
0.330
Why?
Anemia, Sickle Cell
3
2021
324
0.320
Why?
Antibodies, Neutralizing
4
2025
348
0.290
Why?
Hydroxymethylglutaryl-CoA Reductase Inhibitors
2
2024
449
0.260
Why?
Antibodies, Monoclonal
5
2025
1512
0.240
Why?
Heart Defects, Congenital
1
2014
923
0.240
Why?
Crush Injuries
1
2025
14
0.230
Why?
Risk Assessment
1
2014
3712
0.220
Why?
Observational Studies as Topic
1
2025
133
0.210
Why?
Cardiovascular Abnormalities
1
2024
14
0.200
Why?
Freeze Drying
1
2024
79
0.200
Why?
Multicenter Studies as Topic
1
2025
417
0.190
Why?
Clinical Decision-Making
1
2026
365
0.180
Why?
Violence
1
2025
275
0.180
Why?
Plasma
1
2024
222
0.180
Why?
Trauma Centers
1
2025
441
0.180
Why?
Probability
1
2023
309
0.180
Why?
Blood Coagulation
2
2021
267
0.170
Why?
Adult
13
2026
41087
0.160
Why?
Atherosclerosis
1
2024
410
0.150
Why?
Survival Analysis
1
2023
1378
0.150
Why?
Brain Injuries, Traumatic
1
2025
466
0.150
Why?
Proportional Hazards Models
1
2023
1331
0.150
Why?
Prospective Studies
4
2025
8123
0.140
Why?
Renal Circulation
1
2019
75
0.140
Why?
Factor Xa Inhibitors
1
2021
195
0.140
Why?
Rivaroxaban
1
2021
270
0.140
Why?
Albuminuria
1
2019
190
0.140
Why?
Computer Simulation
1
2023
1014
0.140
Why?
Acute Kidney Injury
1
2025
866
0.130
Why?
Anxiety
1
2025
1125
0.130
Why?
Peripheral Arterial Disease
1
2024
507
0.120
Why?
Protein S Deficiency
1
2016
8
0.120
Why?
Humans
19
2026
146342
0.120
Why?
Phosphatidylserines
1
2016
62
0.120
Why?
Middle Aged
9
2025
36619
0.120
Why?
Male
12
2026
73396
0.110
Why?
Hospitalization
4
2022
2475
0.110
Why?
Thrombin
1
2016
175
0.110
Why?
District of Columbia
1
2014
37
0.110
Why?
Virginia
1
2014
57
0.110
Why?
Maryland
1
2014
67
0.110
Why?
Female
12
2026
79499
0.110
Why?
Maternal Age
1
2014
129
0.100
Why?
Risk Factors
5
2025
10921
0.100
Why?
Neutropenia
1
2014
153
0.090
Why?
Renal Insufficiency, Chronic
1
2019
640
0.090
Why?
Endothelium, Vascular
1
2019
952
0.090
Why?
Insurance, Health
1
2015
318
0.090
Why?
Educational Status
1
2014
466
0.090
Why?
Case-Control Studies
2
2016
3647
0.080
Why?
Erythrocytes
1
2016
750
0.080
Why?
Early Detection of Cancer
1
2015
506
0.080
Why?
Patient Acceptance of Health Care
1
2015
881
0.070
Why?
Mothers
1
2014
772
0.070
Why?
Hospital Mortality
1
2013
1051
0.070
Why?
beta-Thalassemia
2
2019
40
0.070
Why?
Cross-Over Studies
2
2021
615
0.070
Why?
Smoking
1
2014
1486
0.060
Why?
Aged
7
2025
26432
0.060
Why?
Practice Guidelines as Topic
1
2015
1591
0.060
Why?
Length of Stay
1
2013
1358
0.060
Why?
Mass Screening
1
2015
1307
0.060
Why?
Health Knowledge, Attitudes, Practice
1
2015
1408
0.060
Why?
Likelihood Functions
1
2026
138
0.060
Why?
Palliative Care
1
2014
1032
0.050
Why?
Double-Blind Method
2
2021
2070
0.050
Why?
Pilot Projects
2
2021
1888
0.050
Why?
Treatment Outcome
3
2025
11821
0.050
Why?
Pulmonary Embolism
1
2026
246
0.050
Why?
Blood Component Transfusion
1
2024
99
0.050
Why?
Infant, Newborn
1
2014
6460
0.050
Why?
Breast Neoplasms
1
2015
2418
0.050
Why?
Antineoplastic Agents
1
2014
2219
0.050
Why?
Urban Population
1
2025
497
0.040
Why?
Treatment Failure
1
2022
361
0.040
Why?
Resuscitation
1
2024
314
0.040
Why?
Infant
1
2014
10114
0.040
Why?
Sickle Cell Trait
1
2019
16
0.040
Why?
Hydroxyurea
1
2019
36
0.040
Why?
Cross-Sectional Studies
2
2024
5899
0.030
Why?
Angiotensin-Converting Enzyme Inhibitors
1
2019
228
0.030
Why?
Neoplasms
1
2013
2954
0.030
Why?
Protein S
1
2016
10
0.030
Why?
Prothrombin
1
2016
25
0.030
Why?
Antithrombin III
1
2016
18
0.030
Why?
Thrombomodulin
1
2016
15
0.030
Why?
Antibodies, Monoclonal, Humanized
1
2022
992
0.030
Why?
Fibrin Fibrinogen Degradation Products
1
2016
92
0.030
Why?
Thrombophilia
1
2016
89
0.030
Why?
Vaccination
1
2024
1449
0.030
Why?
Culture
1
2015
122
0.030
Why?
Chemotherapy-Induced Febrile Neutropenia
1
2014
2
0.030
Why?
Mammography
1
2015
175
0.030
Why?
Depression
1
2024
1575
0.030
Why?
Health Surveys
1
2015
511
0.020
Why?
Blood Platelets
1
2016
382
0.020
Why?
Heart Failure
1
2026
2329
0.020
Why?
Perception
1
2015
373
0.020
Why?
Thrombosis
1
2016
398
0.020
Why?
Surveys and Questionnaires
1
2025
6073
0.020
Why?
Retrospective Studies
2
2025
17438
0.020
Why?
United States
3
2015
16136
0.020
Why?
Health Care Surveys
1
2014
541
0.020
Why?
Socioeconomic Factors
1
2015
1327
0.020
Why?
Rural Population
1
2015
677
0.020
Why?
Obesity
1
2022
3131
0.020
Why?
Registries
1
2014
2400
0.010
Why?
Aged, 80 and over
1
2013
8391
0.010
Why?
Young Adult
1
2016
14330
0.010
Why?
Wogu's Networks
Click the "See All" links for more information and interactive visualizations!
Concepts Expand Description
_
Co-Authors Expand Description
_
Similar People Expand Description
_
Same Department Expand Description

Copyright © 2026 The Regents of the University of Colorado, a body corporate. All rights reserved. (Harvard PROFILES RNS software version: 2.11.1)